Why the study?
Despite national recommendations advocating uptake of new therapies for heart failure, their utilization remains limited and inconsistent across Canada.
This review highlights the gap between guideline recommendations and clinical practice in heart failure management in Canada, emphasizing the need for effective knowledge translation.
Persistent HF therapy gap signals need for better knowledge translation; leaves open which strategies best improve Canadian guideline adherence.
The treatment of heart failure has expanded over the past three decades with large numbers of new medications and healthcare innovations available for these patients. At the same time, the prevalence of heart failure continues to increase across Canada and these patients are managed by a variety of clinicians from differing backgrounds in both primary care and hospital settings. Despite national recommendations advocating uptake of these new therapies, their utilization remains limited and inconsistent across the country. This review discusses the importance of knowledge translation in heart failure and examines the barriers to implementation of new therapies and models of care, providing a range of solutions to facilitate the delivery of guideline-directed care for heart failure patients.
No takes yet. Share an insight, caveat, or question.
Brahmbhatt et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: